Previously submitted to: JMIR Mental Health (no longer under consideration since Jun 25, 2024)
Date Submitted: Jun 25, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Effect of Cardiomyopathy on the Risk of Acute Stress Disorder in Taiwan, 2000-2015
ABSTRACT
Background:
It is now known that determining the comorbidity of COPD and HF leads to a poor prognosis. Our hypothesis that psychological problems predict mortality and that adults with cardiomyopathy will exhibit more psychological problems has predictive that has value in clinical management strategies. At present, research on physical and mental diseases of cardiomyopathy complicated with cardiopulmonary problems is limited.
Objective:
To investigate whether Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD) affect cardiomyopathy and increase Acute Stress Disorder (ASD) risk.
Methods:
Gender, age, and comorbidities were analyzed with 1:4 matching using the National Health Insurance Research Database (NHIRD) of Taiwan in the study. 9,709 patients with cardiomyopathy, 9,623 with ASD, were selected; 38,836 patients without cardiomyopathy, 38,482 with ASD, were also selected. The study using SPSS 22 statistical software to perform Cox regression analysis.
Results:
ASD risk with cardiomyopathy is 1.635 times higher than non-cardiomyopathy. Females are 1.890 times more likely to commit ASD than males. Age 20-49 is 1.819 times more likely to develop ASD than age ≥65. People with CHF have a 1.290 times higher risk of developing ASD than people without CHF. People with COPD had a 1.314 times higher risk of developing ASD than people without COPD.
Conclusions:
Cardiomyopathy increases the risk of ASD, and patients with cardiomyopathy with CHF and COPD have a greater risk of ASD than those without CHF and COPD. Clinicians should be aware of the possibility that CHF and COPD in patients with cardiomyopathy may affect ASD risk.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.